会员体验
专利管家(专利管理)
工作空间(专利管理)
风险监控(情报监控)
数据分析(专利分析)
侵权分析(诉讼无效)
联系我们
交流群
官方交流:
QQ群: 891211   
微信请扫码    >>>
现在联系顾问~
热词
    • 6. 发明申请
    • Soluble rubella E1 envelope protein variants
    • 可溶性风疹E1包膜蛋白变体
    • US20070154883A1
    • 2007-07-05
    • US11584887
    • 2006-10-23
    • Barbara UpmeierRalf BollhagenAlfred EngelElke FaatzPeter SchaarschmidtChristian ScholzToralf Zarnt
    • Barbara UpmeierRalf BollhagenAlfred EngelElke FaatzPeter SchaarschmidtChristian ScholzToralf Zarnt
    • C12Q1/70
    • C07K14/005C07K2319/35C12N2770/36222Y10S530/826
    • The invention disclosed relates to a soluble rubella E1 antigen and variants of this peptide characterized by lacking at the C-terminal end at least the transmembrane region and the anchor segment as well as at least the amino acids 143 to 164 and containing at least the region spanning the disulfide bridges Cys 349-Cys 352 and Cys 368-401 whereas the N-terminus (Cys 349) of this region contains additionally at least 15 amino acids and/or the C-terminus (Cys 401) of this region contains additionally at least 8 amino acids of the adjacent rubella E1 antigen sequence. Also described are a recombinant DNA molecule encoding the rubella E1 antigen and variants which are recombinantly expressed as a chaperone fusion protein, refolded into a soluble and immunoreactive conformation, and further used for the serological detection of anti-rubella antibodies. In addition, also disclosed is a method for the detection, determination and quantification of anti-rubella antibodies of IgG and/or IgM subclass in a sample wherein the rubella E1 antigen is used as a capture reagent and/or binding partner for the antibodies.
    • 所公开的本发明涉及可溶性风疹E1抗原和该肽的变体,其特征在于至少在C-末端缺少至少跨膜区和锚段以及至少氨基酸143至164并且至少含有该区域 跨越二硫键Cys 349-Cys 352和Cys 368-401,而该区域的N末端(Cys 349)另外包含至少15个氨基酸和/或该区域的C末端(Cys 401) 相邻风疹E1抗原序列的至少8个氨基酸。 还描述了编码风疹E1抗原的重组DNA分子和重组表达为伴侣融合蛋白的变体,重新折叠成可溶性和免疫反应性构象,并进一步用于抗风疹抗体的血清学检测。 此外,还公开了用于检测,测定和定量样品中IgG和/或IgM亚类的抗风疹抗体的方法,其中所述风疹E1抗原用作抗体的捕获试剂和/或结合配偶体。